AI-Driven Prognostic Models in Melanoma
Journal: Frontiers in Oncology
Melanoma care has progressed substantially with improved staging frameworks and the adoption of targeted therapies and immune checkpoint inhibitors, yet outc...
Current call-for-papers opportunities for Frontiers in Oncology. Ranking signals: Indexed (Active), JIF 3.3. Use the official publisher page to verify scope and submission rules.
Journal: Frontiers in Oncology
Melanoma care has progressed substantially with improved staging frameworks and the adoption of targeted therapies and immune checkpoint inhibitors, yet outc...
Journal: Frontiers in Oncology
Melanoma care has progressed substantially with improved staging frameworks and the adoption of targeted therapies and immune checkpoint inhibitors, yet outc...
Journal: Frontiers in Oncology
Rare and hard-to-treat skin cancers, such as Merkel cell carcinoma, advanced cutaneous squamous cell carcinoma, refractory basal cell carcinoma, atypical fib...
Journal: Frontiers in Oncology
Rare and hard-to-treat skin cancers, such as Merkel cell carcinoma, advanced cutaneous squamous cell carcinoma, refractory basal cell carcinoma, atypical fib...
Journal: Frontiers in Oncology
Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies worldwide, with disease progression shaped not only by tumor cell-intrinsic ge...
Journal: Frontiers in Oncology
Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies worldwide, with disease progression shaped not only by tumor cell-intrinsic ge...
Journal: Frontiers in Oncology
The tumor microenvironment (TME) is a complex ecosystem consisting of tumor cells, immune cells, nerve fibers, and the extracellular matrix, whose dynamic in...
Journal: Frontiers in Oncology
The tumor microenvironment (TME) is a complex ecosystem consisting of tumor cells, immune cells, nerve fibers, and the extracellular matrix, whose dynamic in...
Journal: Frontiers in Oncology
Genitourinary oncology is being reshaped by advances in molecular biology, precision medicine, artificial intelligence, imaging, and therapeutic innovation. ...
Journal: Frontiers in Oncology
Genitourinary oncology is being reshaped by advances in molecular biology, precision medicine, artificial intelligence, imaging, and therapeutic innovation. ...
Journal: Frontiers in Oncology
Mitochondria are increasingly recognized as central regulators of cancer cell fate, extending far beyond their classical role in bioenergetics. Alterations i...
Journal: Frontiers in Oncology
Mitochondria are increasingly recognized as central regulators of cancer cell fate, extending far beyond their classical role in bioenergetics. Alterations i...
Journal: Frontiers in Oncology
Tonsillar squamous cell carcinoma represents the dominant and most clinically heterogeneous subsite of oropharyngeal squamous cell carcinoma (OPSCC), charact...
Journal: Frontiers in Oncology
Tonsillar squamous cell carcinoma represents the dominant and most clinically heterogeneous subsite of oropharyngeal squamous cell carcinoma (OPSCC), charact...
Journal: Frontiers in Oncology
The increasing integration of advanced imaging, computational technologies and three-dimensional visualization is transforming the planning and the execution...
Journal: Frontiers in Oncology
The increasing integration of advanced imaging, computational technologies and three-dimensional visualization is transforming the planning and the execution...
Journal: Frontiers in Oncology
Recurrent glioblastoma (rGBM) remains one of the hardest problems in neuro-oncology. At relapse, radiotherapy decisions are often limited by uncertain target...
Journal: Frontiers in Oncology
Recurrent glioblastoma (rGBM) remains one of the hardest problems in neuro-oncology. At relapse, radiotherapy decisions are often limited by uncertain target...
Journal: Frontiers in Oncology
Following the success of the first volume of the Research Topic "Exploring Oncolytic Virotherapy in Solid Tumor Treatment" (linked here), Volume II aims to c...
Journal: Frontiers in Oncology
Following the success of the first volume of the Research Topic "Exploring Oncolytic Virotherapy in Solid Tumor Treatment" (linked here), Volume II aims to c...
Journal: Frontiers in Oncology
Head and neck oncology has advanced substantially through improved surgery, radiotherapy, systemic therapies, immunotherapy, and targeted treatments. Neverth...
Journal: Frontiers in Oncology
Head and neck oncology has advanced substantially through improved surgery, radiotherapy, systemic therapies, immunotherapy, and targeted treatments. Neverth...
Journal: Frontiers in Oncology
Neuro-oncology faces persistent challenges in accurately defining tumor extent and assessing treatment response across primary and secondary brain tumors. In...
Journal: Frontiers in Oncology
Neuro-oncology faces persistent challenges in accurately defining tumor extent and assessing treatment response across primary and secondary brain tumors. In...
Journal: Frontiers in Oncology
Immunotherapy has fundamentally rewritten the therapeutic paradigm for head and neck cancers, shifting the clinical standard of care from an exclusive relian...
Journal: Frontiers in Oncology
Immunotherapy has fundamentally rewritten the therapeutic paradigm for head and neck cancers, shifting the clinical standard of care from an exclusive relian...
Journal: Frontiers in Oncology
Minimal residual disease (MRD) detection has emerged as a transformative approach in head and neck oncology, offering unparalleled insights into tumor persis...
Journal: Frontiers in Oncology
Minimal residual disease (MRD) detection has emerged as a transformative approach in head and neck oncology, offering unparalleled insights into tumor persis...
Journal: Frontiers in Oncology
Lung cancer remains the leading cause of cancer-related mortality worldwide, and metastatic disease accounts for the majority of this burden. Despite advance...
Journal: Frontiers in Oncology
Lung cancer remains the leading cause of cancer-related mortality worldwide, and metastatic disease accounts for the majority of this burden. Despite advance...
Journal: Frontiers in Oncology
Liquid biopsy has transformed oncology by enabling minimally invasive access to tumor derived material through circulating tumor DNA, cell free DNA, and rela...
Journal: Frontiers in Oncology
Liquid biopsy has transformed oncology by enabling minimally invasive access to tumor derived material through circulating tumor DNA, cell free DNA, and rela...
Journal: Frontiers in Oncology
Pancreatic cancer remains one of the most challenging malignancies in modern oncology, characterized by aggressive tumor biology, frequent presentation at an...
Journal: Frontiers in Oncology
Pancreatic cancer remains one of the most challenging malignancies in modern oncology, characterized by aggressive tumor biology, frequent presentation at an...
Journal: Frontiers in Oncology
Following the success of the first volume of “Advancing Multidisciplinary Approaches in Skull-Base Tumor Management” here the Volume II edition will continue...
Journal: Frontiers in Oncology
Following the success of the first volume of “Advancing Multidisciplinary Approaches in Skull-Base Tumor Management” here the Volume II edition will continue...
Journal: Frontiers in Oncology
Malnutrition, cachexia and sarcopenia are common in patients with hematologic malignancies and are strongly associated with poor tolerance of treatment, dela...
Journal: Frontiers in Oncology
Malnutrition, cachexia and sarcopenia are common in patients with hematologic malignancies and are strongly associated with poor tolerance of treatment, dela...
Journal: Frontiers in Oncology
Bone and soft tissue cancers encompass one of the most biologically heterogeneous groups of malignancies in oncology, spanning more than 100 histological sub...
Journal: Frontiers in Oncology
Bone and soft tissue cancers encompass one of the most biologically heterogeneous groups of malignancies in oncology, spanning more than 100 histological sub...
Journal: Frontiers in Oncology
Palliative radiotherapy remains a cornerstone for the management of bone metastases, offering crucial relief from pain and preserving quality of life for pat...
Journal: Frontiers in Oncology
Palliative radiotherapy remains a cornerstone for the management of bone metastases, offering crucial relief from pain and preserving quality of life for pat...
Journal: Frontiers in Oncology
Bone cancers present unique clinical challenges for radiation oncologists, whether arising as primary malignancies or as metastatic disease from distant site...
Journal: Frontiers in Oncology
Bone cancers present unique clinical challenges for radiation oncologists, whether arising as primary malignancies or as metastatic disease from distant site...
Journal: Frontiers in Oncology
Treatment resistance remains a central limitation in the pharmacological management of aggressive malignancies, including pancreatic cancer, glioblastoma, tr...
Journal: Frontiers in Oncology
Treatment resistance remains a central limitation in the pharmacological management of aggressive malignancies, including pancreatic cancer, glioblastoma, tr...
Journal: Frontiers in Oncology
Non-Small Cell Lung Cancer (NSCLC) has undergone a profound transformation over the past two decades, evolving from a histology-driven to a biology-driven di...
Journal: Frontiers in Oncology
Non-Small Cell Lung Cancer (NSCLC) has undergone a profound transformation over the past two decades, evolving from a histology-driven to a biology-driven di...
Journal: Frontiers in Oncology
The field of lymphoma genomics has witnessed groundbreaking advances in recent years, particularly in understanding the complex genetic events underlying dis...
Journal: Frontiers in Oncology
The field of lymphoma genomics has witnessed groundbreaking advances in recent years, particularly in understanding the complex genetic events underlying dis...
Journal: Frontiers in Oncology
Colorectal cancer with metastatic disease remains a major surgical and oncologic challenge, despite advances in systemic therapy, cross-sectional imaging, in...
Journal: Frontiers in Oncology
Colorectal cancer with metastatic disease remains a major surgical and oncologic challenge, despite advances in systemic therapy, cross-sectional imaging, in...
Journal: Frontiers in Oncology
Patient-derived tumor organoids have emerged as a transformative preclinical model, bridging the gap between traditional two-dimensional cell cultures and th...
Journal: Frontiers in Oncology
Patient-derived tumor organoids have emerged as a transformative preclinical model, bridging the gap between traditional two-dimensional cell cultures and th...
Journal: Frontiers in Oncology
The treatment landscape for advanced renal cell carcinoma (RCC) has rapidly evolved with the emergence of immune checkpoint inhibitors, targeted therapies, a...
Journal: Frontiers in Oncology
The treatment landscape for advanced renal cell carcinoma (RCC) has rapidly evolved with the emergence of immune checkpoint inhibitors, targeted therapies, a...
Journal: Frontiers in Oncology
Hyperthermia, defined as the controlled elevation of tissue temperature in the range of 39–45 °C, is increasingly recognized as a potent modulator of tumor b...
Journal: Frontiers in Oncology
Hyperthermia, defined as the controlled elevation of tissue temperature in the range of 39–45 °C, is increasingly recognized as a potent modulator of tumor b...
Journal: Frontiers in Oncology
Despite remarkable advances in cancer research, the translation of promising preclinical discoveries into clinically effective combination therapies remains ...
Journal: Frontiers in Oncology
Despite remarkable advances in cancer research, the translation of promising preclinical discoveries into clinically effective combination therapies remains ...
Journal: Frontiers in Oncology
The tumor microenvironment (TME) is a complex ecosystem in which malignant cells, immune populations, stromal components, and endothelial cells interact dyna...
Journal: Frontiers in Oncology
The tumor microenvironment (TME) is a complex ecosystem in which malignant cells, immune populations, stromal components, and endothelial cells interact dyna...
Journal: Frontiers in Oncology
Cancer progression is driven by dysregulated molecular signalling networks that control cell proliferation, survival, metabolism, and immune responses. Key p...
Journal: Frontiers in Oncology
Cancer progression is driven by dysregulated molecular signalling networks that control cell proliferation, survival, metabolism, and immune responses. Key p...
Journal: Frontiers in Oncology
The field of cancer biology has been revolutionized by advances in genomics and targeted therapies, yet major challenges persist in the management of solid t...
Journal: Frontiers in Oncology
The field of cancer biology has been revolutionized by advances in genomics and targeted therapies, yet major challenges persist in the management of solid t...
Journal: Frontiers in Oncology
Breast cancer diagnosis and management increasingly depend on the accurate assessment of tissue-based and molecular biomarkers that guide prognosis, therapeu...
Journal: Frontiers in Oncology
Breast cancer diagnosis and management increasingly depend on the accurate assessment of tissue-based and molecular biomarkers that guide prognosis, therapeu...
Journal: Frontiers in Oncology
Cancer vaccines are re-emerging as a credible immunotherapy class, propelled by advances in antigen discovery, vaccine engineering, and combination strategie...
Journal: Frontiers in Oncology
Cancer vaccines are re-emerging as a credible immunotherapy class, propelled by advances in antigen discovery, vaccine engineering, and combination strategie...
Journal: Frontiers in Oncology
The application of immunotherapy has profoundly changed the field of oncology, with immune checkpoint inhibitors and related agents now recognized as a mains...
Journal: Frontiers in Oncology
The application of immunotherapy has profoundly changed the field of oncology, with immune checkpoint inhibitors and related agents now recognized as a mains...
Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.